Dr Khalid Al Bagdady Neurology Clinic

10/10/2025

Parkinson and Movement disorder Congress Honolulu

24/06/2025

07/09/2024

More nighttime light pollution-> More Alzheimer’s disease

Very interesting
Circadian Rhythm Research Laboratory at Rush University, Chicago published this in Frontiers of Neuroscience.
Artificial nighttime outdoor light is strongly associated with increased risk of Alzheimer’s disease. This was true for people younger and older than 65. And yes, the difference was significant. This was more prevalent in people who have APOE4 genotype. 13% of the population have this genotype by the way. One caveat here is that the study relied on satellite images and not indoor lights. But I think the message is conveyed.nighttime

18/07/2024

Sydney 🇦🇺

17/06/2024

Day 1 at Mayo Clinic Jacksonville Florida, new chapter in my career

17/06/2024

Day 1 at Mayo Clinic, new chapter in my career 🥼

22/05/2024

AZAN 2024 Australian and New Zealand Association of Neurologists

28/03/2024

Just arranged a Stroke treatment ( Clot Retrieval) for a 95 year old man who developed sudden left side arm and leg weakness. The imaging showed a clot in the right side Middle Cerebral artery. The procedure is called Mechanical Thrombectomy, during which the clot (thrombus) is removed and blood circulation restored. The procedure aims at saving the brain tissue (colored green). The brain tissue (colored red) is the core of the infarction and already dead and cannot be saved.

01/12/2023

Very happy to announce that PHARMAC New Zealand has approved Ocrelizumab for the treatment of Primary Progressive Multiple Sclerosis (PPMS) starting from October 1, 2023. I have actually started it on several patients already and it’s great to see the smile on these patients. PPMS is one subtype of Multiple Sclerosis and the patient has to meet specific criteria to be diagnosed as such. These include: progressive neurological symptoms for at least one year and 2 of 3: 1. One or more demyelinative plaques involving specific regions of the brain (supratentorial or infratenrorial), 2: two or more spinal cord lesions or 3: positive Oligoclonal bands in CSF analysis. Ocrelizumab is a humanized monoclonal antibody that selectively targets CD20 B lymphocyte and it’s given as one intravenous infusion every 6 months.

03/10/2023

Split apple rock New Zealand

21/01/2022

https://www.medscape.com/viewarticle/966962

Certain holidays and mega sports events were linked to spikes in alcohol use and, separately, to acute bouts of new atrial fib that could represent teachable moments, optimistic researchers say.